The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Sat, 22.02.2025
UnitedHealth
US91324P1021
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth’s billing practices.
If you currently own...
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or “the Company”) (NYSE: UNH) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/...
The Wall Street Journal continues to report misinformation on the Medicare Advantage (MA) program. The government regularly reviews all MA plans to ensure compliance and we consistently perform at the industry’s highest levels on those reviews. We are not aware of the “launch” of any “new” activity as reported by the Journal. We are aware, however...
UnitedHealth Group (NYSE: UNH) reported full year and fourth quarter 2024 results reflecting diversified growth in serving people more extensively at Optum and UnitedHealthcare.
“The people of UnitedHealth Group remain focused on making high-quality, affordable health care more available to more people while making the health system easier to na...
UnitedHealth Group (NYSE: UNH) will release its fourth quarter and full year 2024 financial results on Thursday, January 16, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors. This call will be webcast on the Investor Relations page of the company’s website (www.unitedh...
UnitedHealth Group today issued the following update:
Claims approval rates
UnitedHealthcare approves and pays about 90% of medical claims upon submission. Importantly, of those that require further review, around one-half of one percent are due to medical or clinical reasons. Highly inaccurate and grossly misleading information has been circ...
UnitedHealth Group today issued the following statement:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241204671702/en/Brian Thompson (Photo: Business Wire)
“We are deeply saddened and shocked at the passing of our dear friend and colleague Brian Thompson, the CEO of UnitedHealthcare....
UnitedHealth Group (NYSE: UNH) issued financial guidance ahead of its annual Investor Conference which takes place on December 4, beginning at 8:00 a.m. ET.
UnitedHealth Group will introduce its 2025 outlook which includes revenues of $450 billion to $455 billion, net earnings of $28.15 to $28.65 per share and adjusted net earnings of $29.50 to ...
UnitedHealth Group (NYSE: UNH) will host its annual Investor Conference for analysts and institutional investors in New York City on Wednesday, December 4, 2024, beginning at 8:00 a.m. EST.
UnitedHealth Group leaders will discuss the company’s long-term strategic growth priorities and its efforts to advance high-quality health care, including th...
The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on December 17, 2024, to all shareholders of record of UNH common stock as of the close of business December 9, 2024.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .